Cyril Garrouste
University of Clermont Auvergne(FR)Metabolism and Renal Physiology(FR)Centre Hospitalier Universitaire de Clermont-Ferrand(FR)Centre Hospitalier Universitaire de Clermont-Ferrand(FR)Société Francophone du Diabète(FR)
Publications by Year
Research Areas
Renal Transplantation Outcomes and Treatments, Renal Diseases and Glomerulopathies, Renal and Vascular Pathologies, Dialysis and Renal Disease Management, Liver Disease and Transplantation
Most-Cited Works
- → Factors Associated With Chronic Hepatitis in Patients With Hepatitis E Virus Infection Who Have Received Solid Organ Transplants(2011)659 cited
- → Development and Validation of a Modified Full Age Spectrum Creatinine-Based Equation to Estimate Glomerular Filtration Rate(2020)365 cited
- → Ribavirin Therapy Inhibits Viral Replication on Patients With Chronic Hepatitis E Virus Infection(2010)276 cited
- → An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants(2020)251 cited
- → Influence of Immunosuppressive Therapy on the Natural History of Genotype 3 Hepatitis-E Virus Infection After Organ Transplantation(2010)230 cited
- → The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment